Lactating females are not eligible unless they have agreed not to breastfeed their infants
Lactating females who plan to breastfeed their infants
Lactating females who plan to breastfeed their infants
Pregnancy and breast feeding:\r\n* Female patients who are pregnant are ineligible\r\n* Lactating females are not eligible unless they have agreed not to breastfeed their infants during treatment and for a period of  month following completion of treatment\r\n* Female patients of childbearing potential are not eligible unless a negative pregnancy test result has been obtained
Lactating females who plan to breastfeed their infants are not eligible
Lactating females are not eligible unless they have agreed not to breastfeed their infant
Lactating females may not participate unless they have agreed not to breastfeed a child while on this study
Lactating females who plan to breastfeed
Lactating females who plan to breastfeed their infants are excluded
Lactating females who plan to breastfeed
Lactating females are not eligible unless they have agreed not to breastfeed their infants
Lactating females are not eligible unless they have agreed not to breastfeed their infants
Lactating females are not eligible unless they have agreed not to breastfeed their infants.
Women who are lactating/breastfeeding or who plan to breastfeed while on sudy through  week after receiving the last dose of study drug
Female patients with infants must agree not to breastfeed their infants while on the study
Female patients with infants must agree not to breastfeed their infants while on the study
Female patients with infants must agree not to breastfeed their infants while on this study
Lactating females are not eligible unless they have agreed not to breastfeed their infants
 Females who are lactating/breastfeeding or who plan to breastfeed while on study through  days after receiving the last dose of study drug.
Women who are lactating/breast feeding or who plan to breastfeed while on study through  week after receiving the last dose of study drug
Lactating females are not eligible unless they have agreed not to breastfeed their infants
Lactating females who plan to breastfeed
Lactating females are not eligible unless they have agreed not to breastfeed their infants
Female patients who are breastfeeding are not eligible for this study unless they agree not to breastfeed
Female patients with infants must agree not to breastfeed their infants while on this study.
Lactating females are not eligible unless they have agreed not to breastfeed their infants
Women who are lactating/breast feeding or who plan to breastfeed while on study through  week after receiving the last dose of study drug
Lactating females are not eligible unless they have agreed not to breastfeed their infants while receiving protocol therapy and for  days after the last dose of lenalidomide
Female patients with infants must agree not to breastfeed their infants while on this study.
Female patients with infants must agree not to breastfeed their infants while on this study.
Lactating females are not eligible unless they have agreed not to breastfeed their infants
Female patients with infants must agree not to breastfeed their infants while on this study.
Lactating females are not eligible unless they have agreed not to breastfeed their infants
Lactating females are not eligible unless they have agreed to not breastfeed their infants
